St. James Investment Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
St. James Investment Company's PFE Position: Q1 2022 in Review
St. James Investment Company sold out of Pfizer (PFE) in Q1 2022, closing a stake of 620,098 shares — an estimated $36.6M sold.
St. James Investment Company first reported a position in PFE in Q1 2020 and held it in 8 quarters. The position peaked at $36.6M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- St. James Investment Company reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
- St. James Investment Company sold 620,098 Pfizer shares in Q1 2022, an estimated $36.6M.
- St. James Investment Company first reported a position in Pfizer in Q1 2020 and held it in 8 quarters.
- St. James Investment Company's Pfizer position peaked at $36.6M in Q4 2021.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on St. James Investment Company's 13F filing for Q1 2022, filed 4 May 2022.